GlassScriptPhysician profile
Aaron Justin Small
NPI 1407015399
$19,558.71
in general payments reported to CMS, 2019-2025
18 companies · $795 in 2025
The $795 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,414 · 2020: $248 · 2021: $4,632 · 2022: $2,485 · 2023: $5,255 · 2024: $728 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,013 · Travel and Lodging: $2,766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,013.18 |
| Travel and Lodging | $2,766.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15,414.67 | 2019-2025 | Orise, Resolution Clip, Microknife Xl |
| Olympus America INC. | $940.80 | 2019-2025 | Endoclot Phs, Single Use Aspiration Needle Na-U200h, Single Use Grasping Forceps |
| Conmed Corporation | $696.42 | 2019-2023 | Conmed Generators, Conmed Biliary |
| Omega Medical Imaging, LLC | $559.98 | 2019-2025 | |
| Olympus Corporation of The Americas | $508.22 | 2019-2020 | |
| Abbvie INC. | $491.97 | 2020-2025 | Skyrizi, Rinvoq, Linzess |
| Ambu INC. | $160.57 | 2024 | |
| Apollo Endosurgery US INC | $131.22 | 2023 | Overstitch Endoscopic Suturing System |
| Cook Medical LLC | $120.07 | 2025 | Echotip Insight |
| Regeneron Healthcare Solutions, INC. | $120.00 | 2023-2025 | Dupixent |
| Celgene Corporation | $109.95 | 2023-2024 | Zeposia |
| Genzyme Corporation | $93.26 | 2023-2025 | |
| Allergan, INC. | $85.42 | 2019-2020 | |
| Medtronic, INC. | $49.80 | 2025 | Pillcam, Nexpowder |
| Astrazeneca Pharmaceuticals LP | $26.84 | 2024 | Imfinzi |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $17.84 | 2024 | Ibsrela |
| Pfizer INC. | $17.40 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.28 | 2024 | Entyvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Small listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.